Home Tags Communicable Diseases
Communicable Diseases Related Content
WHO labels avian influenza as “worrying”, with the possibility of a pandemic
The avian influenza virus is currently having a large strain outbreak called H5N1, which researchers confirm can infect various species.
Molecular aspects of Global Infection Prevention and Control
Dr Zisis Kozlakidis directs our thoughts towards the molecular aspects of global Infection Prevention and Control, in this the second of a special two-part series.
Vulnerable corals can be “rescued” by corals with resistant genotypes
A study finds that disease-resistant corals can help to save vulnerable corals – as genetic diversity improves a coral’s chance of survival.
The next pandemic? UK facing worst bird flu outbreak on record
Christmas is coming, the geese are getting sick, and the world may be three mutations away from the next pandemic: the avian bird flu.
COVID-19, communicable disease and immunology
Academic Research Scholar, Prof Wendy M. Purcell, provides an update on COVID-19, communicable disease and immunology.
Tickborne diseases: A growing health problem in the U.S.
Chief of the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the Centers for Disease Control & Prevention, walks us through a growing health problem in the United States, tickborne diseases.
Preventable asbestos cancer – mesothelioma
Asbestos in over 300,000 public sector buildings continues to put lives at risk. Recommendations to the government for its removal over the next 40 years have been ignored, says Liz Darlison of Mesothelioma UK and Helen Childs, Partner at RWK Goodman.
Keeping up to date with the symptoms of monkeypox
There are important differences in the symptoms of monkeypox between the current outbreak and previous outbreaks in endemic regions.
What are five common monkeypox symptoms?
Here, we look at five key monkeypox symptoms and discuss potential consequences of infection.
Cellular & biological pathways from studies on communicable diseases
Adonis Sfera and Zisis Kozlakidis provide recent insights into cellular and biological pathways from studies on communicable diseases.
Ebola haemorrhagic fever outbreak in Democratic Republic of the Congo
A new case of Ebola haemorrhagic fever has been detected in the Democratic Republic of Congo - healthcare experts say "time is not on our side".
Filling in the gaps of brain immune response
Open Access Government spoke to Dr Robyn S. Klein, MD, PhD, about her ground-breaking work in neuroimmunology and the path to understanding the links between viral encephalitis and memory disorders.
New pandemic of antibiotic resistance makes pneumonia deadly
In Bangladesh, children are fighting a difficult battle to survive antibiotic resistance - now, mid-pandemic, pneumonia is becoming untreatable via normal drugs.
Tailoring the Immune System
Here, Professor Pamela Lein at University of California, Davis, explains how viral vaccines work - especially when it comes to human viral disease.
Diphtheria slowly becomes resistant to antimicrobial treatment
There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.
Pfizer vaccine can reduce COVID hospitalisation and death by 75%
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
ECMO machine reduces COVID-19 deaths by 45% for “sickest patients”
According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.
Consequences of foetal development in a “sweet” uterus: The short-and long-term transgenerational outcomes
Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.
The Moderna vaccine has a final efficiency of 94.1%
The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.
Medical authorities call for better HIV testing in Europe
The European Centre for Disease Control (ECDC) and the World Health Organisation (WHO) found that HIV testing in Europe is not good enough - 53% of diagnosis happens when the immune system is already failing.
12Page 1 of 2